Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Ibandronate in Postmenopausal Women With Osteopenia
NCT00129623Phase 4Completed
- Sponsor
- Roche
- Start
- Dec 2005
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in osteopenia comparing Bonviva 150mg with Placebo (2 arms). Primary endpoint: Relative Change From Baseline in Mean Bone Mineral Density (BMD) of the Lumbar Spine (L2 to L4) at Month 12. Started Dec 2005; status: completed.
02
Drugs
ibandronic acid
03
Conditions
osteopenia
Beyond the preview
Go deeper on NCT00129623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00129623.